Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies

Science. 2005 Jun 24;308(5730):1906-8. doi: 10.1126/science.1111781. Epub 2005 Apr 28.

Abstract

The design of a human immunodeficiency virus-1 (HIV-1) immunogen that can induce broadly reactive neutralizing antibodies is a major goal of HIV-1 vaccine development. Although rare human monoclonal antibodies (mAbs) exist that broadly neutralize HIV-1, HIV-1 envelope immunogens do not induce these antibody specificities. Here we demonstrate that the two most broadly reactive HIV-1 envelope gp41 human mAbs, 2F5 and 4E10, are polyspecific autoantibodies reactive with the phospholipid cardiolipin. Thus, current HIV-1 vaccines may not induce these types of antibodies because of autoantigen mimicry of the conserved membrane-proximal epitopes of the virus. These results may have important implications for generating effective neutralizing antibody responses by using HIV-1 vaccines.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines / immunology
  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antibody Specificity
  • Autoantibodies / chemistry
  • Autoantibodies / immunology*
  • Autoantigens / immunology*
  • Autoimmune Diseases / immunology
  • Cardiolipins / immunology*
  • Cell Line, Tumor
  • Epitopes
  • HIV Antibodies / chemistry
  • HIV Antibodies / immunology*
  • HIV Envelope Protein gp41 / chemistry
  • HIV Envelope Protein gp41 / immunology*
  • HIV Infections / immunology
  • HIV-1 / immunology*
  • Humans
  • Mice
  • Molecular Mimicry
  • Neutralization Tests

Substances

  • AIDS Vaccines
  • Antibodies, Monoclonal
  • Autoantibodies
  • Autoantigens
  • Cardiolipins
  • Epitopes
  • HIV Antibodies
  • HIV Envelope Protein gp41